IVIG Shortage


What is IVIG?

Intravenous immunoglobulin (IVIG) is a blood product used to treat a variety of medical conditions. IVIG is often used as a preventative treatment for patients with conditions affecting their immune system. It is also sometimes needed as an urgent treatment for patients facing immediate, life-threatening illnesses.

Why is there an IVIG shortage, and how long is it expected to last?

The root cause of the shortage is not known. This is a nationwide shortage, many hospitals are experiencing the same problem and the end to the shortage is unknown.

Who receives IVIG treatments?

BIDMC patients who receive care through the following departments may have their care impacted:

  • Oncology
  • Hematology
  • Neurology
  • Infectious Disease
  • Transplant
  • Bone Marrow Transplant
  • Obstetrics
  • Rheumatology
  • Allergy
  • Immunology

Is the IVIG shortage affecting BIDMC patients?

Yes. Some patients are experiencing temporary interruptions in their IVIG treatments in order to ensure we have enough IVIG for patients who are facing life-threatening illnesses.

What is BIDMC doing to help patients during the shortage?

We are monitoring the current supply and planning short-term solutions. BIDMC and providers are in the process of reaching out to affected patients. When we have restored a sufficient supply of IVIG, care teams will resume treatment with patients.

Will this shortage affect my treatment plan?

The shortage is affecting many patients who receive routine IVIG treatments, but BIDMC care teams are doing everything possible to identify alternative treatment plans. We are also working to obtain more IVIG from manufacturers as soon as it is available.

Are there any alternatives patients should consider?

Patients should speak to a member of their care team to determine if other treatment options should be pursued during the shortage.

Please contact your provider's office with any questions.